Moody Aldrich Partners LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 936941 MARBLEHEAD, MA

Position in PTGX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$7,305,890

+$1,625,568 QoQ

Shares Held

59,601

+10.6% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

1.31%

of 13F equity value

Holder Rank

#82

of 341 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 47% Shared 36% None 16%

Healthcare · as of Jun 30, 2026

Moody Aldrich Partners LLC holds $91,411,685 across 28 Biotechnology names. PTGX ranks #3 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ORKA	Oruka Therapeutics, Inc.	101,411	$9,651,284
2	LGND	Ligand Pharmaceuticals Inc	28,160	$8,901,094
3	PTGX	Protagonist Therapeutics, Inc This page	59,601	$7,305,890
4	DNTH	Dianthus Therapeutics, Inc. /DE/	74,552	$7,267,328
5	PRAX	Praxis Precision Medicines, Inc.	19,066	$6,383,106
6	CRNX	Crinetics Pharmaceuticals, Inc.	146,077	$5,466,201
7	NKTR	Nektar Therapeutics	64,135	$4,477,264
8	CAPR	Capricor Therapeutics, Inc.	177,754	$4,280,316

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,305,890	59,601	+10.6%	Shares	Sole	2026-07-15
2026-03-31	$5,680,322	53,893	-33.2%	Shares	Sole	2026-04-20
2025-12-31	$7,041,612	80,623	-43.6%	Shares	Sole	2026-01-30
2025-09-30	$9,503,475	143,060	-16.1%	Shares	Sole	2025-10-21
2025-06-30	$9,427,403	170,570	+4.3%	Shares	Sole	2025-08-04
2025-03-31	$7,906,037	163,483	+142.5%	Shares	Sole	2025-04-29
2024-12-31	$2,602,219	67,415	-43.5%	Shares	Sole	2025-01-23
2024-09-30	$5,367,915	119,287	-11.1%	Shares	Sole	2024-10-22
2024-06-30	$4,650,549	134,215	+33.5%	Shares	Sole	2024-07-24
2024-03-31	$2,908,014	100,519	+61.3%	Shares	Sole	2024-04-30
2023-12-31	$1,429,158	62,327	-9.6%	Shares	Sole	2024-01-26
2023-09-30	$1,150,386	68,968	+64.8%	Shares	Sole	2023-11-08
2023-06-30	$1,156,173	41,860	—	Shares	Sole	2023-07-28
No filing history on record for this holder in this stock.